These innovative medications , including Semaglutide , belong to a group of drugs called GLP-1 receptor agonists . Initially developed for managing diabetes mellitus , they operate by helping the organism to produce adequate the hormone insulin and limiting high sugar levels. Furthermore , their ability to support slimming has resulted to increased